Cargando…
Inhibitory Effects of Apium graveolens on Xanthine Oxidase Activity and Serum Uric Acid Levels in Hyperuricemic Mice
Celery (Apium graveolens) is traditionally used to treat rheumatism and cardiovascular disorders. Hyperuricemia is considered as a predisposing factor for gout and is also suggested to be associated with coronary artery disease. In the present study, the effect of hydroalcoholic extracts from A. gra...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Food Science and Nutrition
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047868/ https://www.ncbi.nlm.nih.gov/pubmed/30018891 http://dx.doi.org/10.3746/pnf.2018.23.2.127 |
_version_ | 1783340004332797952 |
---|---|
author | Dolati, Karim Rakhshandeh, Hassan Golestani, Mohsen Forouzanfar, Fatemeh Sadeghnia, Roya Sadeghnia, Hamid R. |
author_facet | Dolati, Karim Rakhshandeh, Hassan Golestani, Mohsen Forouzanfar, Fatemeh Sadeghnia, Roya Sadeghnia, Hamid R. |
author_sort | Dolati, Karim |
collection | PubMed |
description | Celery (Apium graveolens) is traditionally used to treat rheumatism and cardiovascular disorders. Hyperuricemia is considered as a predisposing factor for gout and is also suggested to be associated with coronary artery disease. In the present study, the effect of hydroalcoholic extracts from A. graveolens (AGE) against potassium oxonate (PO)-induced hyperuricemia was investigated in mice. AGE (250, 500, and 1,000 mg/kg) or allopurinol (5 mg/kg, as positive control) were orally administrated 1 h after PO injection (250 mg/kg, ip) for two weeks. After that, the serum uric acid level and hepatic xanthine dehydrogenase (XDH) and xanthine oxidase (XO) activities were measured. In addition, the antioxidant activity of AGE was determined by assessment of hepatic lipid peroxidation, in vivo and the ferric reducing/antioxidant power assay, in vitro. The extract exhibited good capacity to reduce ferric ion to ferrous ion with mean value of 63.8±8.5 μmol/g. The data also showed that oxonate treatment produced a significant increase in serum uric acid level (4.6 vs. 2.3 mg/ dL, P<0.001), liver XO/XDH activities (P<0.01 and P<0.001, respectively), and hepatic lipid peroxides levels (about two fold, P<0.01), compared to the healthy mice. AGE significantly decreased the serum uric acid level, hepatic XO/XDH activities, and lipid peroxidation, in a dose-dependent manner. Oral administration of 1,000 mg/kg AGE for two weeks reversed the elevated serum uric acid level (2.7 vs. 4.6 mg/dL, P<0.001) and significantly inhibited liver XO/XDH activities (P<0.001) and diminished hepatic lipid peroxidation (0.45 vs. 0.82 nmol/mg protein, P<0.05), compared with hyperuricemic mice. AGE (1,000 mg/kg) per se did not significantly modify these parameters. Our results demonstrated that AGE could reduce the serum uric acid level via inhibition of hepatic XDH/XO and indicated its potential utility as an effective hypouricemic bioactive agent or functional food. |
format | Online Article Text |
id | pubmed-6047868 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The Korean Society of Food Science and Nutrition |
record_format | MEDLINE/PubMed |
spelling | pubmed-60478682018-07-17 Inhibitory Effects of Apium graveolens on Xanthine Oxidase Activity and Serum Uric Acid Levels in Hyperuricemic Mice Dolati, Karim Rakhshandeh, Hassan Golestani, Mohsen Forouzanfar, Fatemeh Sadeghnia, Roya Sadeghnia, Hamid R. Prev Nutr Food Sci Articles Celery (Apium graveolens) is traditionally used to treat rheumatism and cardiovascular disorders. Hyperuricemia is considered as a predisposing factor for gout and is also suggested to be associated with coronary artery disease. In the present study, the effect of hydroalcoholic extracts from A. graveolens (AGE) against potassium oxonate (PO)-induced hyperuricemia was investigated in mice. AGE (250, 500, and 1,000 mg/kg) or allopurinol (5 mg/kg, as positive control) were orally administrated 1 h after PO injection (250 mg/kg, ip) for two weeks. After that, the serum uric acid level and hepatic xanthine dehydrogenase (XDH) and xanthine oxidase (XO) activities were measured. In addition, the antioxidant activity of AGE was determined by assessment of hepatic lipid peroxidation, in vivo and the ferric reducing/antioxidant power assay, in vitro. The extract exhibited good capacity to reduce ferric ion to ferrous ion with mean value of 63.8±8.5 μmol/g. The data also showed that oxonate treatment produced a significant increase in serum uric acid level (4.6 vs. 2.3 mg/ dL, P<0.001), liver XO/XDH activities (P<0.01 and P<0.001, respectively), and hepatic lipid peroxides levels (about two fold, P<0.01), compared to the healthy mice. AGE significantly decreased the serum uric acid level, hepatic XO/XDH activities, and lipid peroxidation, in a dose-dependent manner. Oral administration of 1,000 mg/kg AGE for two weeks reversed the elevated serum uric acid level (2.7 vs. 4.6 mg/dL, P<0.001) and significantly inhibited liver XO/XDH activities (P<0.001) and diminished hepatic lipid peroxidation (0.45 vs. 0.82 nmol/mg protein, P<0.05), compared with hyperuricemic mice. AGE (1,000 mg/kg) per se did not significantly modify these parameters. Our results demonstrated that AGE could reduce the serum uric acid level via inhibition of hepatic XDH/XO and indicated its potential utility as an effective hypouricemic bioactive agent or functional food. The Korean Society of Food Science and Nutrition 2018-06 2018-06-30 /pmc/articles/PMC6047868/ /pubmed/30018891 http://dx.doi.org/10.3746/pnf.2018.23.2.127 Text en Copyright © 2018 by The Korean Society of Food Science and Nutrition This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Articles Dolati, Karim Rakhshandeh, Hassan Golestani, Mohsen Forouzanfar, Fatemeh Sadeghnia, Roya Sadeghnia, Hamid R. Inhibitory Effects of Apium graveolens on Xanthine Oxidase Activity and Serum Uric Acid Levels in Hyperuricemic Mice |
title | Inhibitory Effects of Apium graveolens on Xanthine Oxidase Activity and Serum Uric Acid Levels in Hyperuricemic Mice |
title_full | Inhibitory Effects of Apium graveolens on Xanthine Oxidase Activity and Serum Uric Acid Levels in Hyperuricemic Mice |
title_fullStr | Inhibitory Effects of Apium graveolens on Xanthine Oxidase Activity and Serum Uric Acid Levels in Hyperuricemic Mice |
title_full_unstemmed | Inhibitory Effects of Apium graveolens on Xanthine Oxidase Activity and Serum Uric Acid Levels in Hyperuricemic Mice |
title_short | Inhibitory Effects of Apium graveolens on Xanthine Oxidase Activity and Serum Uric Acid Levels in Hyperuricemic Mice |
title_sort | inhibitory effects of apium graveolens on xanthine oxidase activity and serum uric acid levels in hyperuricemic mice |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047868/ https://www.ncbi.nlm.nih.gov/pubmed/30018891 http://dx.doi.org/10.3746/pnf.2018.23.2.127 |
work_keys_str_mv | AT dolatikarim inhibitoryeffectsofapiumgraveolensonxanthineoxidaseactivityandserumuricacidlevelsinhyperuricemicmice AT rakhshandehhassan inhibitoryeffectsofapiumgraveolensonxanthineoxidaseactivityandserumuricacidlevelsinhyperuricemicmice AT golestanimohsen inhibitoryeffectsofapiumgraveolensonxanthineoxidaseactivityandserumuricacidlevelsinhyperuricemicmice AT forouzanfarfatemeh inhibitoryeffectsofapiumgraveolensonxanthineoxidaseactivityandserumuricacidlevelsinhyperuricemicmice AT sadeghniaroya inhibitoryeffectsofapiumgraveolensonxanthineoxidaseactivityandserumuricacidlevelsinhyperuricemicmice AT sadeghniahamidr inhibitoryeffectsofapiumgraveolensonxanthineoxidaseactivityandserumuricacidlevelsinhyperuricemicmice |